ResearcherBirmingham VA Medical CenterNo recent work listed
Yong Sun
Matched on ORCID iD 0000-0001-5720-2779; OpenAlex author ID A5055389940, A5101026851. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper
Papers 5
- Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation. Co-author DOI 10.1038/s41374-019-0365-z↗
- Cytoplasmic PARP-1 promotes pancreatic cancer tumorigenesis and resistance. First author DOI 10.1002/ijc.32108↗
- Reciprocal regulation of DGCR5 and miR-320a affects the cellular malignant phenotype and 5-FU response in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.18377↗
- Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer. First author DOI 10.18632/oncotarget.4490↗
- PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy. First author DOI 10.1158/1078-0432.ccr-13-0516↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tong Zhou · 4 shared papers, 2013–2020 · strength 0.33
- Paper Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation. DOI 10.1038/s41374-019-0365-z↗
- Paper Cytoplasmic PARP-1 promotes pancreatic cancer tumorigenesis and resistance. DOI 10.1002/ijc.32108↗
- Paper Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer. DOI 10.18632/oncotarget.4490↗
- Yabing Chen · 4 shared papers, 2013–2020 · strength 0.33
- Paper Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation. DOI 10.1038/s41374-019-0365-z↗
- Paper Cytoplasmic PARP-1 promotes pancreatic cancer tumorigenesis and resistance. DOI 10.1002/ijc.32108↗
- Paper Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer. DOI 10.18632/oncotarget.4490↗
- Fei Xu · 3 shared papers, 2015–2020 · strength 0.29
- Paper Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation. DOI 10.1038/s41374-019-0365-z↗
- Paper Cytoplasmic PARP-1 promotes pancreatic cancer tumorigenesis and resistance. DOI 10.1002/ijc.32108↗
- Paper Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer. DOI 10.18632/oncotarget.4490↗
- Shanzhong Yang · 2 shared papers, 2019–2020 · strength 0.23
- Kaiyu Yuan · 3 shared papers, 2013–2020 · strength 0.23
- Paper Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation. DOI 10.1038/s41374-019-0365-z↗
- Paper Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer. DOI 10.18632/oncotarget.4490↗
- Paper PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy. DOI 10.1158/1078-0432.ccr-13-0516↗
- Nirag Chandrakant Jhala · 1 shared paper, 2019 · strength 0.11
- Ling Liu · 1 shared paper, 2017 · strength 0.07
- Yabin Yu · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.